Program Book

Morning
8.30-9.20 Poster presentations Rbp100-120
(moderators C. Shields, P. Chevez-Barrios)
9.20-10.25 Papers
(moderators A.C. Moll, M.W. Wilson)
152 RB1
GUIDELINES FOR IMAGING OF RETINOBLASTOMA:
DIAGNOSTIC IMAGING STRATEGY AND STANDARD-
IZED MR IMAGING PROTOCOL
P. de Graaf, S. Göricke , F.Rodjan , P. Galluzzi, P. Maeder, J.A. Castelijns,
H.J. Brisse on behalf of the European Retinoblastoma Imaging
Collaboration (ERIC)
1831 RB2
CHEMOTHERAPY FOCAL THERAPY AND BEYOND:
THE IMPORTANCE OF CLINICAL TRIALS & THE ROLE OF
A RETINOBLASTOMA CLINICAL STUDIES CONGLOMER-
ATE.
Helen Dimaras, Ashwin C. Mallipatna, Brenda L. Gallie, Helen S.L. Chan.
1846 RB3
RETINOBLASTOMA: ANALYSIS OF MORTALITY IN UZ-
BEKISTAN
Z. Islamov, F. Islom
1201 RB4
INCIDENCE OF RETINOBLASTOMA IN THE NETHER-
LANDS 1950 - 2010: A SHIFT IN THE PROPORTION OF
HEREDITARY RETINOBLASTOMA.
M.I. Bosscha, L. Razzaq, C.J. Dommering, F.E. van Leeuwen, A.C. Moll
1844 RB5
EARLY DELIVERY OF INFANTS FOR TREATMENT OF
RETINOBLASTOMA DIAGNOSED BY PRENATAL RB1
MUTATION IDENTIFICATION
Brenda L. Gallie, Helen Dimaras, Elise Héon, Joanne Sutherland, Megan
Day, Vikas Khetan, Gardiner Jane, Helen Chan
43 RB6
CLINICAL AND GENETIC FEATURES OF REGRESSED
RETINOBLASTOMA
Manoj Parulekar, Archana Kulkarni, Trevor Cole, Bruce Morland, Helen
Jenkinson, Sarah Turner, John Ainsworth
47 RB7
RETINOBLASTOMA PATIENTS WITH CHROMOSOME
13Q DELETIONS HAVE INCREASED CHEMOTHERAPY-
RELATED TOXICITIES
R.C. Brennan, I. Qaddoumi, C. Billups, C. Odom, T. Douglas, W. Furman, M.W. Wilson
Tuesday November 15, 2011
RETINOBLASTOMA
Program
29
10.20-10.50 BREAK
10.50-12.25 Papers
(moderators L. Desjardins, L. Teixeira)
358 RB8
TOPOTECAN IS EFFECTIVE IN ADVANCED INTRAOCU-
LAR RETINOBLASTOMA WITH MANAGEABLE TOXIC-
ITY
Ibrahim Qaddoumi, Catherine Billups, Clinton F. Stewart, Jianrong Wu,
Katherine Helton, Mary McCarville, Thomas E. Merchant, Rachel Brennan,
Barrett G. Haik, Carlos Rodriguez-Galindo, Matthew W. Wilson
619 RB9
LACK OF ACUTE TOXICITY FOLLOWING STANDARD
DOSE CARBOPLATIN, ETOPOSIDE AND VINCRISTINE:
RESULTS FROM CHILDREN’S ONCOLOGY GROUP
STUDY ARET-0332
A. Leahey, P. Chevez-Barrios, B. Langholz, A. Javed, V. Khetan, S. Honavar,
R. Eagle, D. Albert J. O’Brien, K. Matthay, A. Meadows, M. Chintagumpala
1615 RB10
CONSERVATIVE TREATMENT OF INTRAOCULAR RETIN-
OBLASTOMA: A PROSPECTIVE PHASE II RANDOMIZED
TRIAL OF NEOADJUVANT CHEMOTHERAPY FOLLOWED
BY LOCAL TREATMENT
Livia Lumbroso-Le Rouic, Isabelle Aerts, David Hajaje, Christine Lévy-
Gabriel, Alexia Savignoni, Nathalie Algret, François Doz, Laurence
Desjardins
24 RB11
OUTCOMES OF 105 EYES WITH INTRAOCULAR RETIN-
OBLASTOMA TREATED WITH SYSTEMIC CHEMOTHER-
APY AND/OR LOCAL THERAPY AS FIRST TREATMENT
Luiz F. Teixeira, Carla R. Donato Macedo, Virginia L. Torres, Camila H.
Hashimoto, Juliana dos Santos Soares, Clelia M. Erwenne
1546 RB12
BRACHYTHERAPY IN THE TREATMENT OF RETINO-
BLASTOMA. EXPERIENCE IN A SPANISH POPULATION
Mónica Asencio-Duran, José Abelairas, José-María Peralta, José-Maria
Fernández-Guardiola, Ernesto Sánchez-jacob,
2130 RB13
RADIOTHERAPY IN COMPLEX TREATMENT OF AD-
VANCED RETINOBLASTOMA IN CHILDREN
Tatiana Ushakova, Igor Glekov, Olga Gopovtzova, Igor Dolgopolov,
Alentina Pavlovskaya, Irina Matveeva, Vladimir Polyakov, Geordge
Mentkevich